
Data is unavailable

Data is unavailable
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net worth | 2372.24 | 1808.69 | 1783.28 | 1822.19 | 1478.67 | 1329.36 | 1197.58 | 1085.03 | 986.90 | 639.26 | 546.94 | 396.45 | 320.42 | 275.98 | 224.68 | 101.27 | 58.67 | 56.00 |
| Fixed assets | 1417.84 | 1384.86 | 1368.33 | 1341.84 | 1110.53 | 650.44 | 558.01 | 534.20 | 491.93 | 393.41 | 316.06 | 294.42 | 180.67 | 166.61 | 146.25 | 147.55 | 144.51 | 87.85 |
| Debt | 586.36 | 935.59 | 797.04 | 681.91 | 844.09 | 389.88 | 194.04 | 191.07 | 241.46 | 90.73 | 188.61 | 118.42 | 131.56 | 60.66 | 56.60 | 76.97 | 112.68 | 88.28 |
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 132.18 | 136.67 | 179.92 | 105.13 | 46.93 | 124.38 | 146.78 | 44.92 | 37.48 | 128.70 | 68.81 | 70.04 | 43.64 | 56.73 | 40.86 | 53.52 | 29.74 |
| Investing | -199.08 | -166.58 | -232.61 | -285.50 | -404.28 | -289.52 | -196.16 | -8.76 | -262.23 | -109.20 | -195.12 | -48.93 | -95.21 | -152.31 | 7.77 | -18.26 | -52.66 |
| Financing | 62.65 | 46.78 | 45.80 | 82.86 | 436.37 | 175.50 | 10.06 | -60.91 | 312.70 | -19.65 | 136.21 | -28.34 | 66.31 | 10.02 | 35.93 | -36.69 | 12.40 |

BSE on June 19, 1995; NSE on December 03, 2009.
91.58%.
Manufacture of APIs, intermediates, formulations, new drug delivery systems, peptides, biotech products, and specialty chemicals.